Impact of Cytochrome P450 3A and ATP-Binding Cassette Subfamily B Member 1 Polymorphisms on Tacrolimus Dose-Adjusted Trough Concentrations Among Korean Renal Transplant Recipients-Reference-Cited by-同舟云学术

Impact of Cytochrome P450 3A and ATP-Binding Cassette Subfamily B Member 1 Polymorphisms on Tacrolimus Dose-Adjusted Trough Concentrations Among Korean Renal Transplant Recipients

Published:2012-01 Issue:1 Volume:44 Page:109-114
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Cho J.-H.,Yoon Y.-D.,Park J.-Y.,Song E.-J.,Choi J.-Y.,Yoon S.-H.,Park S.-H.,Kim Y.-L.,Kim C.-D.

Funder

Kyungpook National University Hospital

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference21 articles.

1. Tacrolimus based immunosuppression;First;J Nephrol,2004

2. The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring;Felipe;Clin Transplant,2002

3. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics;Iwasaki;Drug Metab Pharmacokinet,2007

4. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression;Kuehl;Nat Genet,2001

5. Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region;Westlind;Biochem Biophys Res Commun,1999

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequencies and Association of CYP3A5 Polymorphism With Tacrolimus Concentration Among Renal Transplant Recipients in Vietnam;Transplantation Proceedings;2022-10

2. Early impact of donor CYP3A5 genotype and Graft-to-Recipient Weight Ratio on tacrolimus pharmacokinetics in pediatric liver transplant patients;Scientific Reports;2021-01-11

3. The tacrolimus metabolism affect post‐transplant outcome mediating acute rejection and delayed graft function: analysis from Korean Organ Transplantation Registry data;Transplant International;2020-11-09

4. Tacrolimus trough levels higher than 6 ng/mL might not be required after a year in stable kidney transplant recipients;PLOS ONE;2020-07-02

5. Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype‐guided doses in renal transplantation patients;British Journal of Clinical Pharmacology;2019-07-03